Pradaxa Lawsuit MDL Update: Judge Issues Stay of All Motions
By Andrea Gressman
Judge David R. Herndon has issued an indefinite stay of all pending motions in the Pradaxa lawsuit multidistrict litigation (MDL). He has issued this stay to structure future proceedings and to allow Pradaxa lawsuit lawyers interested in the case to apply for leadership positions in the Pradaxa lawsuit MDL. This brings Pradaxa bleeding lawsuits pending the MDL one step closer to hopefully securing a Pradaxa lawsuit settlement for their internal bleeding injuries.
Time Running Out to Join the Pradaxa Lawsuit MDL
Pretrial proceedings have already begun for the Pradaxa lawsuit MDL, yet many Pradaxa internal bleeding lawsuits with motions pending have been transferred to the Pradaxa lawsuit MDL from other courts. According to Herndon’s order, some of the motions raise common questions present in many Pradaxa bleeding lawsuits in the MDL. The Pradaxa lawsuit stay was established so decisions to these questions could be made after the establishment of the Pradaxa MDL structure.
The Pradaxa MDL was created on August 8, 2012 in the Southern District of Illinois to consolidate the growing number of Pradaxa bleeding injury lawsuits filed against the drug’s manufacturer, Boehringer Ingelheim. Pradaxa lawsuits Plaintiffs claim they suffered injuries resulting from the anticoagulant Pradaxa. There were nearly 80 Pradaxa bleeding lawsuits in the Pradaxa lawsuit MDL by the end of August.
Pradaxa Side Effects Lead to Hundreds of Adverse Event Reports
Pradaxa, approved in 2010, was marketed as more user-friendly than it’s counterpart warfarin (Coumadin), as it did not require a strict diet or consistent blood level monitoring. While internal bleeding side effects exist with both warfarin and Pradaxa, warfarin users can treat their internal bleeding with vitamin K. Pradaxa users, on the other hand, have no way to treat their internal bleeding, hemorrhaging or gastrointestinal bleeding once they occur.
The FDA was flooded with thousands of adverse event reports about Pradaxa within just 14 months of approving the drug. This includes 900 cases of Pradaxa gastrointestinal bleeding, and 500 Pradaxa death cases caused uncontrollable Pradaxa bleeding.
Common Pradaxa Side Effects
Shortly after Pradaxa was approved it was discovered that there were many different severe side effects of Pradaxa that were actually considered life threatening. Some of these include the following:
* Severe and uncontrollable intestinal bleeding
* Gastrointestinal bleeding
* Brain hemorrhage
* Kidney bleeding
* Internal bleeding
* Heart attack
* And even death
If you or someone you love has experienced any of the side effects of Pradaxa listed above, including internal bleeding, gastrointestinal bleeding, brain hemorrhage, kidney bleeding, internal bleeding, heart attack, or even death and were also taking Pradaxa, you may be eligible to join the Pradaxa Internal Bleeding Class Action Lawsuit Investigation.
Updated October 2nd, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
